205 related articles for article (PubMed ID: 18830568)
1. Activated human neutrophils rapidly release the chemotactically active D2D3 form of the urokinase-type plasminogen activator receptor (uPAR/CD87).
Pliyev BK
Mol Cell Biochem; 2009 Jan; 321(1-2):111-22. PubMed ID: 18830568
[TBL] [Abstract][Full Text] [Related]
2. Release of the soluble urokinase-type plasminogen activator receptor (suPAR) by activated neutrophils in rheumatoid arthritis.
Pliyev BK; Menshikov MY
Inflammation; 2010 Feb; 33(1):1-9. PubMed ID: 19756998
[TBL] [Abstract][Full Text] [Related]
3. A soluble form of the urokinase plasminogen activator receptor (suPAR) can bind to hematopoietic cells.
Mizukami IF; Todd RF
J Leukoc Biol; 1998 Aug; 64(2):203-13. PubMed ID: 9715260
[TBL] [Abstract][Full Text] [Related]
4. Cellular glycosylphosphatidylinositol-specific phospholipase D regulates urokinase receptor shedding and cell surface expression.
Wilhelm OG; Wilhelm S; Escott GM; Lutz V; Magdolen V; Schmitt M; Rifkin DB; Wilson EL; Graeff H; Brunner G
J Cell Physiol; 1999 Aug; 180(2):225-35. PubMed ID: 10395292
[TBL] [Abstract][Full Text] [Related]
5. Urokinase-catalysed cleavage of the urokinase receptor requires an intact glycolipid anchor.
Høyer-Hansen G; Pessara U; Holm A; Pass J; Weidle U; Danø K; Behrendt N
Biochem J; 2001 Sep; 358(Pt 3):673-9. PubMed ID: 11535128
[TBL] [Abstract][Full Text] [Related]
6. The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R.
Resnati M; Pallavicini I; Wang JM; Oppenheim J; Serhan CN; Romano M; Blasi F
Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1359-64. PubMed ID: 11818541
[TBL] [Abstract][Full Text] [Related]
7. Proteolytic regulation of the urokinase receptor/CD87 on monocytic cells by neutrophil elastase and cathepsin G.
Beaufort N; Leduc D; Rousselle JC; Magdolen V; Luther T; Namane A; Chignard M; Pidard D
J Immunol; 2004 Jan; 172(1):540-9. PubMed ID: 14688365
[TBL] [Abstract][Full Text] [Related]
8. Role of formic receptors in soluble urokinase receptor-induced human vascular smooth muscle migration.
Duru EA; Fu Y; Davies MG
J Surg Res; 2015 May; 195(2):396-405. PubMed ID: 25758338
[TBL] [Abstract][Full Text] [Related]
9. The receptor for urokinase regulates TLR2 mediated inflammatory responses in neutrophils.
Liu G; Yang Y; Yang S; Banerjee S; De Freitas A; Friggeri A; Davis KI; Abraham E
PLoS One; 2011; 6(10):e25843. PubMed ID: 21998707
[TBL] [Abstract][Full Text] [Related]
10. Clinical relevance and cellular source of elevated soluble urokinase plasminogen activator receptor (suPAR) in acute liver failure.
Koch A; Zimmermann HW; Gassler N; Jochum C; Weiskirchen R; Bruensing J; Buendgens L; Dückers H; Bruns T; Gerken G; Neumann UP; Adams DH; Trautwein C; Canbay A; Tacke F
Liver Int; 2014 Oct; 34(9):1330-9. PubMed ID: 24575897
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of tumour-derived urokinase receptor and receptor fragments in cancer patients and xenografted mice.
Sier CF; Nicoletti I; Santovito ML; Frandsen T; Aletti G; Ferrari A; Lissoni A; Giavazzi R; Blasi F; Sidenius N
Thromb Haemost; 2004 Feb; 91(2):403-11. PubMed ID: 14961171
[TBL] [Abstract][Full Text] [Related]
12. Participation of the urokinase-type plasminogen activator receptor (uPAR) in neutrophil transendothelial migration.
Pliyev BK; Antonova OA; Menshikov M
Mol Immunol; 2011 May; 48(9-10):1168-77. PubMed ID: 21470685
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 infected lymphoid organs upregulate expression and release of the cleaved form of uPAR that modulates chemotaxis and virus expression.
Nebuloni M; Zawada L; Ferri A; Tosoni A; Zerbi P; Resnati M; Poli G; Genovese L; Alfano M
PLoS One; 2013; 8(7):e70606. PubMed ID: 23923008
[TBL] [Abstract][Full Text] [Related]
14. Mapping the interaction between high molecular mass kininogen and the urokinase plasminogen activator receptor.
Mahdi F; Shariat-Madar Z; Kuo A; Carinato M; Cines DB; Schmaier AH
J Biol Chem; 2004 Apr; 279(16):16621-8. PubMed ID: 14764580
[TBL] [Abstract][Full Text] [Related]
15. Increased soluble urokinase plasminogen activator receptor (suPAR) is associated with thrombosis and inhibition of plasmin generation in paroxysmal nocturnal hemoglobinuria (PNH) patients.
Sloand EM; Pfannes L; Scheinberg P; More K; Wu CO; Horne M; Young NS
Exp Hematol; 2008 Dec; 36(12):1616-24. PubMed ID: 18954937
[TBL] [Abstract][Full Text] [Related]
16. Shedding and cleavage of the urokinase receptor (uPAR): identification and characterisation of uPAR fragments in vitro and in vivo.
Sidenius N; Sier CF; Blasi F
FEBS Lett; 2000 Jun; 475(1):52-6. PubMed ID: 10854857
[TBL] [Abstract][Full Text] [Related]
17. Reduced release of intact and cleaved urokinase receptor in stimulated whole-blood cultures from human immunodeficiency virus-1-infected patients.
Ostrowski SR; Piironen T; Høyer-Hansen G; Gerstoft J; Pedersen BK; Ullum H
Scand J Immunol; 2005 Apr; 61(4):347-56. PubMed ID: 15853918
[TBL] [Abstract][Full Text] [Related]
18. The D2D3 form of uPAR acts as an immunotoxin and may cause diabetes and kidney disease.
Zhu K; Mukherjee K; Wei C; Hayek SS; Collins A; Gu C; Corapi K; Altintas MM; Wang Y; Waikar SS; Bianco AC; Koch A; Tacke F; Reiser J; Sever S
Sci Transl Med; 2023 Sep; 15(714):eabq6492. PubMed ID: 37729431
[TBL] [Abstract][Full Text] [Related]
19. Neutrophils are a main source of circulating suPAR predicting outcome in critical illness.
Gussen H; Hohlstein P; Bartneck M; Warzecha KT; Buendgens L; Luedde T; Trautwein C; Koch A; Tacke F
J Intensive Care; 2019; 7():26. PubMed ID: 31061709
[TBL] [Abstract][Full Text] [Related]
20. The cleavage of the urokinase receptor regulates its multiple functions.
Montuori N; Carriero MV; Salzano S; Rossi G; Ragno P
J Biol Chem; 2002 Dec; 277(49):46932-9. PubMed ID: 12297505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
